Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Perspectives on Cervical Cancer Prevention Strategies and a Combination Treatment for Cervical Precancer in South African Women Living with HIV and Male Partners

Nicholas S. Teodoro, Nkosinathi Ngcobo, Milenka Jean-Baptiste, Masangu Mulongo, Cecilia Milford, Malgorzata Beksinska, Jaqueline Burgess, Sibusisiwe Luvuno, Jermina Nkoana, Nonkululeko Mayisela, Lisa Rahangdale, Carla J. Chibwesha
doi: https://doi.org/10.1101/2025.01.07.25320108
Nicholas S. Teodoro
1University of North Carolina at Chapel Hill, Department of Obstetrics and Gynecology, Chapel Hill, North Carolina, United States of America
2Wits Health Consortium, Clinical HIV Research Unit, Helen Joseph Hospital, Johannesburg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nkosinathi Ngcobo
2Wits Health Consortium, Clinical HIV Research Unit, Helen Joseph Hospital, Johannesburg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Milenka Jean-Baptiste
3University of North Carolina at Chapel Hill, Gillings School of Global Public Health, Chapel Hill, North Carolina, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masangu Mulongo
2Wits Health Consortium, Clinical HIV Research Unit, Helen Joseph Hospital, Johannesburg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cecilia Milford
4Wits Health Consortium, MatCH Research Unit, Durban, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Malgorzata Beksinska
4Wits Health Consortium, MatCH Research Unit, Durban, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jaqueline Burgess
2Wits Health Consortium, Clinical HIV Research Unit, Helen Joseph Hospital, Johannesburg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sibusisiwe Luvuno
2Wits Health Consortium, Clinical HIV Research Unit, Helen Joseph Hospital, Johannesburg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jermina Nkoana
2Wits Health Consortium, Clinical HIV Research Unit, Helen Joseph Hospital, Johannesburg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nonkululeko Mayisela
2Wits Health Consortium, Clinical HIV Research Unit, Helen Joseph Hospital, Johannesburg, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa Rahangdale
1University of North Carolina at Chapel Hill, Department of Obstetrics and Gynecology, Chapel Hill, North Carolina, United States of America
5University of North Carolina at Chapel Hill, Center for AIDS Research, Chapel Hill, North Carolina, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carla J. Chibwesha
1University of North Carolina at Chapel Hill, Department of Obstetrics and Gynecology, Chapel Hill, North Carolina, United States of America
2Wits Health Consortium, Clinical HIV Research Unit, Helen Joseph Hospital, Johannesburg, South Africa
5University of North Carolina at Chapel Hill, Center for AIDS Research, Chapel Hill, North Carolina, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: carla_chibwesha{at}med.unc.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Introduction Cervical cancer remains the second most common cancer among women worldwide, with 85% of cases occurring in low-and middle-income countries (LMIC). Women living with HIV (WLWH) are at a particularly high risk of developing for high-grade cervical intraepithelial neoplasia (CIN2/3) and cervical cancer, and the standard surgical treatment is far less effective in this population. Thus, research on medical therapies and combination treatment options remain a priority. In preparation for a clinical trial involving adjuvant intravaginal 5-fluorouracil (5FU) cream following surgical treatment for CIN2/3, we explored the acceptability of our proposed intervention among WLWH and male partners.

Methods We conducted qualitative interviews with WLWH and male partners in Johannesburg, South Africa between April 2022 and September 2022. We invited WLWH to participate in semi-structured focus group discussions (FGDs), while male partners were invited to participate in semi-structured in-depth interviews (IDIs). The analysis utilized a rapid, deductive approach in which quotations were identified and categorized into relevant domains: factors affecting cervical cancer screening, the initiation of 5FU vaginal cream, and adherence to 5FU.

Results We conducted 9 FGDs comprising 48 WLWH and 18 IDIs with male partners. The mean age of participants was 43 years, and the majority (75%) had completed secondary education. Most women (75%) had also undergone Pap smear screening and 50% had a prior abnormal Pap smear. Qualitative analysis revealed that education on HPV and cervical cancer, prior experience with the health system, and social perceptions/stigma influenced cervical cancer screening uptake and were important factors in the initiation of and adherence to 5FU. Men’s knowledge about cervical cancer was extremely limited. Overall, participants’ perceptions of the proposed trial intervention were positive, with most participants expressing confidence that women would be able to use and adhere to the intravaginal 5FU cream. Concerns raised included possible effects of 5FU on fertility, contraceptive requirements, and the recommendation for brief periods of abstinence following cream use to prevent partner side effects.

Conclusions Although participants had some cervical cancer knowledge, misperceptions about HPV and cervical cancer were common and prevented follow-up for abnormal Pap results. Participants emphasized the need for thorough counseling about 5FU, citing this as integral for uptake. Utilizing stakeholder input to design the clinical trial is necessary to promote acceptability and adherence to the trial intervention.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

CJC and LR are funded by the United States National Institutes of Health (NIH) to study combination treatment approaches for cervical precancer in women living with HIV (R01 CA250850). Trainee support for NST was provided by NIH (T32 HD075731) and MJB was also supported by NIH through the NC Translational and Clinical Sciences (NC TraCS) Institute (UM1TR004406). The NIH was not involved in the conduct of the study, interpretation of its results, or our decision to submit results for publication.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Prior to conducting this study, we obtained ethical approval from the University of Witwatersrand Human Research Ethics Committee (M200543) and the University of North Carolina at Chapel Hill Institutional Review Board (20-1227).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Footnotes

  • Funding: CJC and LR are funded by the United States National Institutes of Health (NIH) to study combination treatment approaches for cervical precancer in women living with HIV (R01 CA250850). Trainee support for NST was provided by NIH (T32 HD075731) and MJB was also supported by NIH through the NC Translational and Clinical Sciences (NC TraCS) Institute (UM1TR004406). The NIH was not involved in the conduct of the study, interpretation of its results, or our decision to submit results for publication.

  • Statements and Declarations: The authors declare no commercial or other financial conflicts of interest.

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted January 07, 2025.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Perspectives on Cervical Cancer Prevention Strategies and a Combination Treatment for Cervical Precancer in South African Women Living with HIV and Male Partners
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Perspectives on Cervical Cancer Prevention Strategies and a Combination Treatment for Cervical Precancer in South African Women Living with HIV and Male Partners
Nicholas S. Teodoro, Nkosinathi Ngcobo, Milenka Jean-Baptiste, Masangu Mulongo, Cecilia Milford, Malgorzata Beksinska, Jaqueline Burgess, Sibusisiwe Luvuno, Jermina Nkoana, Nonkululeko Mayisela, Lisa Rahangdale, Carla J. Chibwesha
medRxiv 2025.01.07.25320108; doi: https://doi.org/10.1101/2025.01.07.25320108
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Perspectives on Cervical Cancer Prevention Strategies and a Combination Treatment for Cervical Precancer in South African Women Living with HIV and Male Partners
Nicholas S. Teodoro, Nkosinathi Ngcobo, Milenka Jean-Baptiste, Masangu Mulongo, Cecilia Milford, Malgorzata Beksinska, Jaqueline Burgess, Sibusisiwe Luvuno, Jermina Nkoana, Nonkululeko Mayisela, Lisa Rahangdale, Carla J. Chibwesha
medRxiv 2025.01.07.25320108; doi: https://doi.org/10.1101/2025.01.07.25320108

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Obstetrics and Gynecology
Subject Areas
All Articles
  • Addiction Medicine (434)
  • Allergy and Immunology (758)
  • Anesthesia (222)
  • Cardiovascular Medicine (3313)
  • Dentistry and Oral Medicine (366)
  • Dermatology (282)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1175)
  • Epidemiology (13397)
  • Forensic Medicine (19)
  • Gastroenterology (900)
  • Genetic and Genomic Medicine (5175)
  • Geriatric Medicine (482)
  • Health Economics (785)
  • Health Informatics (3283)
  • Health Policy (1145)
  • Health Systems and Quality Improvement (1198)
  • Hematology (432)
  • HIV/AIDS (1023)
  • Infectious Diseases (except HIV/AIDS) (14651)
  • Intensive Care and Critical Care Medicine (915)
  • Medical Education (478)
  • Medical Ethics (128)
  • Nephrology (525)
  • Neurology (4950)
  • Nursing (262)
  • Nutrition (734)
  • Obstetrics and Gynecology (888)
  • Occupational and Environmental Health (797)
  • Oncology (2530)
  • Ophthalmology (730)
  • Orthopedics (284)
  • Otolaryngology (348)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (547)
  • Pediatrics (1305)
  • Pharmacology and Therapeutics (552)
  • Primary Care Research (558)
  • Psychiatry and Clinical Psychology (4223)
  • Public and Global Health (7525)
  • Radiology and Imaging (1713)
  • Rehabilitation Medicine and Physical Therapy (1018)
  • Respiratory Medicine (981)
  • Rheumatology (480)
  • Sexual and Reproductive Health (500)
  • Sports Medicine (425)
  • Surgery (551)
  • Toxicology (72)
  • Transplantation (237)
  • Urology (206)